Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterization

Acta Pharmacologica Sinica

Volumn 28, Issue 11, 2007, Pages 1851-1858

  Qin, Xiang Qi ^a   Yuan, Yuan ^a   Liu, Chang Sheng ^a   Wang, Qiu Yun ^b   Shen, Xi ^a   Yang, Bai Can ^b  

^a East China University of Science and Technology   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Analgesic; Anti inflammatory; Attenuation; Liposomal brucine; Sustained release; Synergia; Transdermal formulation

Indexed keywords

ACETIC ACID; BRUCINE; CHOLESTEROL; DEOXYCHOLATE SODIUM; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; XYLENE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SAFETY; DRUG SYNTHESIS; EDEMA; ENCAPSULATION; FEMALE; IN VITRO STUDY; LD 50; LIPOSOMAL DELIVERY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; SKIN IRRITATION; SKIN PERMEABILITY; SKIN TEST; WRITHING TEST;

ADMINISTRATION, CUTANEOUS; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG DELIVERY SYSTEMS; FEMALE; LIPOSOMES; MALE; RABBITS; SKIN; STRYCHNINE;

EID: 35648971626     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00654.x     Document Type: Article

References (16)

1. Chinese Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China Volume I. Beijing : Chemical Industry Press 2005.
2. Yin W, Wang TS, Yin FZ, Cai BC. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. J Ethnopharmacol 2003 88 : 205 14.
3. Zhu YN, Bao MZ, Chen D, Liu H, Li JT, Yan HT, et al. Study on the toxicity of brucine in mice. Henan Med Res 1994 3 : 107 9. Chinese.
4. Torchilin V, Weissing, V Liposomes (A Practical Approach). Oxford : IRL Press/Oxford University Press 1990.
5. Srinath P, Vyas SP, Diwan PV. Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev Ind Pharm 2000 26 : 313 21.
6. Singh AK, Das J. Liposome encapsulated vitamin A compounds exhibit greater stability and diminished toxicity. Biophys Chem 1998 73 : 155 62.
7. Atif A, Krishna KP, Farhan JA, Yashomati D, Zeenat IK, Divya V. Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in mice. Eur Neuropsychopharmacol 2007 17 : 227 9.
8. Schmid MH, Korting HC. Liposomes: a drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst 1994 11 : 97 118.
9. Touitou E, Junginger HE, Weiner ND, Nagai N, Mezei M. Lipo-somes as carriers for topical and transdermal delivery. Int J Pharm 1994 83 : 1189 203.
10. Zhang GF, Zhu JB, Zhuang Y, Hu J. Study on optimize the preparation and formulation of nimodipine-containing nanolipo-some. J Chin Pharm Univ 2003 34 : 25 8.
11. Lboutounne H, Guillaume YC, Michel L, Makki S, Humbert PH, Millet J. Study and development of encapsulated form of 4, 5, 8-trimethylpsoralen for topical drug delivery. Drug Dev Res 2004 61 : 86 94.
12. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies. Food Chem Toxicol 2006 44 : 636 50.
13. Michael S, Taharat Y, Anthony EK, Aimee LL, Jason B, Karrie AB, et al. Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex. J Inorg Biochem 2005 99 : 2161 83.
14. Tang, XC, Lin, ZG, Cai, W, Chen, N, Shen L. Anti-inflammatory effect of 3-acetylaconitine. Acta Pharmacol Sin 1984 5 : 85 9.
15. Koster R, Anderson M, De Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959 18 : 412 6.
16. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003 258 : 141 51.